TMCnet News
Research and Markets: Global Molecular Diagnostics (Infectious Disease Testing, Blood Screening, Cancer Screening) 2014-2020 - Strategic Business ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/tkzn5n/molecular) has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousands by the following Applications: Infectious Disease Testing, Blood Screening, Cancer Screening, and Other Applications. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company prfiles are primarily based on public domain information including company URLs. The report profiles 165 companies including many key and niche players such as: - Abbott Laboratories - Becton, Dickinson and Company - bioMérieux SA - Cepheid - CytoCore Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Medical Diagnostics Market A Review 3. Molecular Diagnostics Industry An Overview 4. An Insight Into Applications Of Molecular Diagnostics 5. Competitive Dynamics In The Molecular Diagnostics Market 6. Product & Technology Overview 7. Product Approvals/Introductions 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 165 (including Divisions/Subsidiaries 179)
For more information visit http://www.researchandmarkets.com/research/tkzn5n/molecular
|
